Washington University has a long history of research in the area of imaging. Investigations on the clinical application ofthe first computed tomography scanner were carried out at Washington University and positron emission tomography was initially developed here. The Oncologic Imaging Program emphasizes the development of novel imaging agents for nuclear imaging, MR imaging and optical imaging, as well as the application of a variety of imaging techniques to oncologic problems. The Program's research is focused in the following areas: (1) the development of new imaging agents, (2) the development of new techniques in the area of molecular imaging, (3) the extension of agents initially designed for imaging to therapeutic applications with unsealed sources, and (4) the application of modern imaging techniques for the evaluation and planning of radiation treatment. The Oncologic Imaging Program has the goal of expanding collaboration on the application of imaging techniques to answer specific questions in the other programs. The Program is applying its expertise in small animal imaging to collaborations with the Basic Science Programs as well as translating basic science research into human populations with the Translational and Clinical Research, Breast Cancer Research and Prevention and Control Programs. The Oncologic Imaging Program has 35 members from 7 Departments and 2 Schools. The Program is supported by $17,044,040 in funding, of which $7,896,692 is NCI funding and $7,962,056 is other peerreviewed funding. In the last grant period, members ofthe Oncologic imaging Program published 423 manuscripts, of which 26% represented inter-programmatic and 16% represented intra-programmatic collaborations.

Public Health Relevance

The Oncologic Imaging Program at the Siteman Cancer Center has a major goal of developing new imaging techniques, validating them in animal models of cancer, and translating them to patients. Examples of imaging techniques that have been developed and translated to patient studies are the imaging of receptors involved in breast and prostate cancer as well as imaging agents for measuring tumor cell growth and the oxygenation levels (hypoxia) of tumors. These agents will be used in patients both to diagnose tumors and to predict the preferred therapy for individual patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-12
Application #
8520207
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
12
Fiscal Year
2013
Total Cost
$60,201
Indirect Cost
$53,162
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Abboud, Ramzi; Keller, Jesse; Slade, Michael et al. (2016) Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated. Biol Blood Marrow Transplant 22:1851-60
Johnson, Kimberly J; Zoellner, Nancy L; Gutmann, David H (2016) Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1. Cancer Epidemiol 42:53-9
Zuiani, Adam; Chen, Kevin; Schwarz, Megan C et al. (2016) A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I. J Virol 90:10499-10512
Chou, Chun; Verbaro, Daniel J; Tonc, Elena et al. (2016) The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses. Immunity 45:570-82
Durai, Vivek; Murphy, Kenneth M (2016) Functions of Murine Dendritic Cells. Immunity 45:719-736
Brownson, Ross C; Dodson, Elizabeth A; Kerner, Jon F et al. (2016) Framing research for state policymakers who place a priority on cancer. Cancer Causes Control 27:1035-41
Mertins, Philipp; Mani, D R; Ruggles, Kelly V et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534:55-62
Niu, Haixia; Hadwiger, Gayla; Fujiwara, Hideji et al. (2016) Pathways of retinoid synthesis in mouse macrophages and bone marrow cells. J Leukoc Biol 99:797-810
Beeman, Scott C; Shui, Ying-Bo; Perez-Torres, Carlos J et al. (2016) O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models. Magn Reson Med 75:2442-7
Fehniger, Todd A; Cooper, Megan A (2016) Harnessing NK Cell Memory for Cancer Immunotherapy. Trends Immunol 37:877-888

Showing the most recent 10 out of 947 publications